SG11202013029UA - Pyridopyrimidinone derivatives for use as axl inhibitors - Google Patents
Pyridopyrimidinone derivatives for use as axl inhibitorsInfo
- Publication number
- SG11202013029UA SG11202013029UA SG11202013029UA SG11202013029UA SG11202013029UA SG 11202013029U A SG11202013029U A SG 11202013029UA SG 11202013029U A SG11202013029U A SG 11202013029UA SG 11202013029U A SG11202013029U A SG 11202013029UA SG 11202013029U A SG11202013029U A SG 11202013029UA
- Authority
- SG
- Singapore
- Prior art keywords
- axl inhibitors
- pyridopyrimidinone derivatives
- pyridopyrimidinone
- derivatives
- axl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862690620P | 2018-06-27 | 2018-06-27 | |
| PCT/KR2019/007733 WO2020004938A1 (en) | 2018-06-27 | 2019-06-26 | Pyridopyrimidinone derivatives for use as axl inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202013029UA true SG11202013029UA (en) | 2021-01-28 |
Family
ID=68987456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202013029UA SG11202013029UA (en) | 2018-06-27 | 2019-06-26 | Pyridopyrimidinone derivatives for use as axl inhibitors |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20210275532A1 (en) |
| EP (1) | EP3814350A4 (en) |
| JP (1) | JP7200453B2 (en) |
| KR (1) | KR20210014212A (en) |
| CN (1) | CN112351985B (en) |
| AU (1) | AU2019292207B2 (en) |
| BR (1) | BR112020026641A2 (en) |
| CA (1) | CA3103160C (en) |
| CL (1) | CL2020003340A1 (en) |
| EA (1) | EA202190125A1 (en) |
| IL (1) | IL279593A (en) |
| MX (1) | MX2020013805A (en) |
| SG (1) | SG11202013029UA (en) |
| WO (1) | WO2020004938A1 (en) |
| ZA (1) | ZA202100140B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3814348T3 (en) | 2018-06-27 | 2023-10-30 | Bristol Myers Squibb Co | SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL112249A (en) * | 1994-01-25 | 2001-11-25 | Warner Lambert Co | Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds |
| RS49779B (en) * | 1998-01-12 | 2008-06-05 | Glaxo Group Limited, | Byciclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| US8404677B2 (en) | 2009-10-29 | 2013-03-26 | Genosco | Kinase inhibitors |
| AU2013235344B2 (en) * | 2012-03-22 | 2017-03-16 | Oscotec Inc. | Substituted pyridopyrimidine compounds and their use as FLT3 inhibitors |
| US9533989B2 (en) * | 2012-09-18 | 2017-01-03 | Ziarco Pharma Ltd. | Substituted pyrimidine-5-carboxamides as spleen tyrosine kinase inhibitors |
| GB201509338D0 (en) * | 2015-05-29 | 2015-07-15 | Bergenbio As | Combination therapy |
| WO2017059280A1 (en) * | 2015-10-02 | 2017-04-06 | The University Of North Carolina At Chapel Hill | Novel pan-tam inhibitors and mer/axl dual inhibitors |
| EP3469001A4 (en) | 2016-06-09 | 2020-05-06 | Seattle Genetics, Inc. | Combinations of pbd-based antibody drug conjugates with flt3 inhibitors |
-
2019
- 2019-06-26 KR KR1020217002865A patent/KR20210014212A/en not_active Application Discontinuation
- 2019-06-26 US US17/255,589 patent/US20210275532A1/en active Pending
- 2019-06-26 MX MX2020013805A patent/MX2020013805A/en unknown
- 2019-06-26 BR BR112020026641-8A patent/BR112020026641A2/en unknown
- 2019-06-26 CN CN201980043846.4A patent/CN112351985B/en active Active
- 2019-06-26 JP JP2020567743A patent/JP7200453B2/en active Active
- 2019-06-26 SG SG11202013029UA patent/SG11202013029UA/en unknown
- 2019-06-26 AU AU2019292207A patent/AU2019292207B2/en active Active
- 2019-06-26 WO PCT/KR2019/007733 patent/WO2020004938A1/en unknown
- 2019-06-26 EA EA202190125A patent/EA202190125A1/en unknown
- 2019-06-26 CA CA3103160A patent/CA3103160C/en active Active
- 2019-06-26 EP EP19826848.4A patent/EP3814350A4/en active Pending
-
2020
- 2020-12-20 IL IL279593A patent/IL279593A/en unknown
- 2020-12-21 CL CL2020003340A patent/CL2020003340A1/en unknown
-
2021
- 2021-01-08 ZA ZA2021/00140A patent/ZA202100140B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN112351985A (en) | 2021-02-09 |
| WO2020004938A1 (en) | 2020-01-02 |
| EP3814350A4 (en) | 2022-05-04 |
| IL279593A (en) | 2021-03-01 |
| EP3814350A1 (en) | 2021-05-05 |
| JP2021528383A (en) | 2021-10-21 |
| JP7200453B2 (en) | 2023-01-10 |
| MX2020013805A (en) | 2021-03-09 |
| CA3103160A1 (en) | 2020-01-02 |
| BR112020026641A2 (en) | 2021-03-30 |
| US20210275532A1 (en) | 2021-09-09 |
| ZA202100140B (en) | 2022-07-27 |
| CA3103160C (en) | 2023-03-07 |
| AU2019292207B2 (en) | 2022-06-30 |
| CN112351985B (en) | 2023-12-15 |
| CL2020003340A1 (en) | 2021-04-23 |
| AU2019292207A1 (en) | 2021-02-18 |
| EA202190125A1 (en) | 2021-05-24 |
| KR20210014212A (en) | 2021-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273428B1 (en) | Heterocyclic compounds as pad inhibitors | |
| ZA202002770B (en) | Imidazo-pyridine compounds as pad inhibitors | |
| IL277455A (en) | Aminopyrimidine derivatives as ctps1 inhibitors | |
| HRP20200133T1 (en) | New substituted cyanoindoline derivatives as nik inhibitors | |
| IL276269A (en) | Aminopyrrolotriazines as kinase inhibitors | |
| IL282659A (en) | Heterocyclic compounds as bet inhibitors | |
| IL279453B (en) | Pyrazole derivatives as malt1 inhibitors | |
| HK1257565A1 (en) | New trifluoromethylpropanamide derivatives as htra1 inhibitors | |
| IL277518A (en) | Substituted imidazolidin-2-one derivatives as prmt5 inhibitors | |
| IL279452B (en) | Pyrazole derivatives as malt1 inhibitors | |
| HK1257567A1 (en) | New difluoroketamide derivatives as htra1 inhibitors | |
| IL271808A (en) | New substituted azaindoline derivatives as nik inhibitors | |
| IL268565B (en) | Pyrazole derivatives as bromodomain inhibitors | |
| HK1252767A1 (en) | Pyrazol-pyridine derivatives as eaat3 inhibitors | |
| ZA202100140B (en) | Pyridopyrimidinone derivatives for use as axl inhibitors | |
| ZA201908372B (en) | Pyridoquinazoline derivatives useful as protein kinase inhibitors | |
| LT3827005T (en) | Pyridopyrimidines as histamine h4-receptor inhibitors | |
| SG11202006394YA (en) | Benzotriazole derivatives as corrosion inhibitors |